Cindy Tahl, General Counsel and Secretary at FATE THERAPEUTICS INC (FATE), sold 100,000 shares at $58.96 ($5.9M) on 2021-10-01, disclosed to the SEC on 2021-10-04.
Open-market sale of $5.9M FATE by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.03 | 16,312 | $947K | 16.1% |
| 2 | $58.03 | 16,312 | $947K | 16.1% |
| 3 | $58.96 | 21,844 | $1.3M | 21.9% |
| 4 | $58.96 | 21,844 | $1.3M | 21.9% |
| 5 | $59.68 | 11,844 | $707K | 12.0% |
| 6 | $59.68 | 11,844 |
| $707K |
| 12.0% |
| Total | $58.83 avg | 100,000 | $5.9M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $11K | — | Filing → |
| FATE | SELL | 2025-08-05 | $10K | — | Filing → |
| FATE | SELL | 2025-01-13 | $9K | — | Filing → |